Quoin Pharmaceuticals Ltd... (QNRX)
NASDAQ: QNRX
· Real-Time Price · USD
7.50
0.20 (2.67%)
At close: Aug 15, 2025, 3:34 PM
7.48
-0.20%
After-hours: Aug 15, 2025, 04:04 PM EDT
Quoin Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 100.37K | n/a | n/a | n/a | 154.77K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 25.52K | 24.87K | n/a | 25.07K | 24.91K | 25.28K | 25.95K | 25.91K | 25.7K | 25.77K | 25.94K | 25.8K | 25.7K | 26.07K | 26.13K | n/a | 58.24K | 25.74K |
Gross Profit | -25.52K | -24.87K | 50.19K | -25.07K | -24.91K | -25.28K | -25.95K | -25.91K | -25.7K | -25.77K | -25.94K | -25.8K | -25.7K | -26.07K | -26.13K | n/a | -58.24K | -25.74K |
Operating Income | -3.87M | -3.96M | -2.41M | -2.53M | -2.13M | -2.46M | -2.22M | -2.12M | -2.11M | -2.82M | -2.03M | -2.32M | -2.67M | -2.18M | 2.61M | -1.3M | -976.89K | -1.39M |
Interest Income | 105.39K | 144.87K | 109.33K | 146.39K | 165.26K | 137.51K | 158.55K | 196.43K | 187.59K | 152.05K | 80.61K | 15.13K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -3.77M | -3.81M | -2.31M | -2.35M | -1.97M | -2.33M | -2.05M | -1.93M | -2.11M | -2.6M | -2M | -3.03M | -2.67M | -1.68M | -11.82M | -1.4M | -4.34M | -3.9M |
Net Income | -3.7M | -3.81M | -2.31M | -2.35M | -1.97M | -2.35M | -2.05M | -1.93M | -2.11M | -2.38M | -1.97M | -3.74M | -2.67M | -1.19M | -21.46B | -1.4M | -4.34M | -3.9M |
Selling & General & Admin | 1.74M | 1.58M | 1.33M | 1.36M | 1.61M | 1.63M | 1.39M | 1.37M | 1.63M | 1.68M | 1.47M | 1.58M | 1.94M | 1.59M | 1.97M | 1.04M | 737.61K | 744.97K |
Research & Development | 2.05M | 2.37M | 1.07M | 1.17M | 492.55K | 826.9K | 832.39K | 758.76K | 625.1K | 1.09M | 613.07K | 745.51K | 726.69K | 587.57K | 1.01M | 260K | 239.28K | 56.79K |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -1.92K | n/a | -34.47K | 20.43K | 4.36K | -3.05K | n/a | 77.24K | n/a | n/a | -2.97M | -500K |
Operating Expenses | 3.79M | 3.96M | 2.41M | 2.53M | 2.1M | 2.46M | 2.22M | 2.13M | 2.26M | 2.78M | 2.09M | 2.33M | 2.67M | 2.18M | 2.98M | 1.3M | 976.89K | 801.76K |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 714.08K | n/a | n/a | 574.13K | 248.16K | 202.51K | 65.6K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -5.9K | 17.92K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 3.87M | 3.96M | 2.41M | 2.53M | 2.13M | 2.49M | 2.22M | 2.13M | 2.26M | 2.78M | 2.09M | 2.33M | 2.67M | 2.18M | 2.98M | 1.3M | 976.89K | 801.76K |
Income Tax Expense | n/a | n/a | n/a | -8.95B | 1.97M | n/a | n/a | n/a | -187.59K | -218.92K | -26.01K | 714.08K | 2.79 | -493.24K | -7.69M | n/a | n/a | n/a |
Shares Outstanding (Basic) | 588.17K | 586.33K | 186.51K | 5M | 5.05M | 2.1M | 987.22K | 987.22K | 987.22K | 987.22K | 403.88K | 274.37K | 274.37K | 55.91K | 45K | 20K | 20K | 20K |
Shares Outstanding (Diluted) | 588.17K | 586.33K | 186.51K | 5M | 5.05M | 2.1M | 987.22K | 987.22K | 987.22K | 987.22K | 403.88K | 274.37K | 274.37K | 55.92K | 45.2K | 20.03K | 20.03K | 20.03K |
EPS (Basic) | -6.28 | -6.5 | -12.37 | -16.45 | -0.39 | -1.12 | -2.1 | -1.95 | -2.13 | -2.42 | -4.89 | -13.64 | -9.72 | -21.28 | -476.81K | -70.21 | -216.88 | -195.19 |
EPS (Diluted) | -6.28 | -6.5 | -12.41 | -16.45 | -0.39 | -1.12 | -2.1 | -1.95 | -2.13 | -2.42 | -4.89 | -13.64 | -9.72 | -21.27 | -474.66K | -70.11 | -216.57 | -194.92 |
EBITDA | -3.75M | -3.93M | -2.38M | -2.5M | -2.11M | -2.43M | -2.19M | -1.89M | -2.23M | -2.75M | -1.97M | -2.29M | -2.64M | -2.15M | -11.85M | -1.28M | -1.58M | -3.77M |
EBIT | -3.77M | -3.96M | -2.41M | -2.53M | -2.14M | -2.46M | -2.22M | -1.92M | -2.26M | -2.78M | -2M | -2.32M | -2.67M | -2.18M | -11.24M | -1.16M | -1.64M | -3.8M |
Depreciation & Amortization | 25.52K | 25K | 25.2K | 25.07K | 24.91K | 25.28K | 25.67K | 25.91K | 25.7K | 25.77K | 25.94K | 25.8K | 25.7K | 26.07K | 26.13K | 26.01K | 58.24K | 25.74K |